Your fact-checks will appear here
Swiss-American multinational pharmaceutical corporation
OpenSecrets and related reporting show that pharmaceutical/health‑product PACs spent about $16.05 million on federal candidates in the 2024 cycle . Multiple outlets compiling OpenSecrets data list top...
Available reporting shows industrywide totals and past recipient lists but no single authoritative list in the provided sources naming “which senators receive the largest campaign donations from pharm...
OpenSecrets reports Pharmaceuticals/Health Products PACs gave $16,054,355 to federal candidates in 2024 (industry total), and company PACs such as Pfizer and Merck were major players in 2023–24 giving...
There is no reporting in the documents provided that says Donald Trump personally invested capital into pharmaceutical companies or pharmaceutical-focused investment funds; the available sources descr...
Financial services, communications/electronics and allied professional sectors were among the largest sources of industry money flowing to Democratic campaigns in 2024, with major Democratic recipient...
Clinical‑level patient data from many randomized statin trials have been shared with researchers through controlled‑access channels, but public reporting rarely lists trial names; an influential harmo...
There is no publicly verifiable “most animal testing” drug company because companies and regulators do not publish comparable, centralized totals of animals used across jurisdictions and research type...
There is no single, universally accepted technical standard for anonymizing patient‑level clinical trial data; instead a patchwork of statistical metrics, industry guidance, platform rules and nationa...
The American Heart Association (AHA) publishes year-by-year disclosures listing pharmaceutical, biotech and device-company support, and those disclosures show a recurring set of large donors across th...
Nine major drugmakers — Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech (Roche’s U.S. unit), Gilead Sciences, GSK (including ViiV), Merck, Novartis and Sanofi — agreed to sell selected me...
Yes — nine major pharmaceutical companies publicly agreed to lower the price of some of their medicines in deals announced by the Trump administration on Dec. 19, 2025, committing to “most-favored-nat...
Neurocept’s public profile in the available sources is limited: there are no press releases or filings about a company named “Neurocept” changing a drug-development pipeline tied to Dr. Paul Alan Cox ...
The $130,000 payment to Stormy Daniels was routed through , a Delaware entity set up and controlled by Michael Cohen, who acknowledged making the payment at the direction of a federal candidate and la...